Related Experiment Video
Updated: Mar 26, 2026

In Vivo Osteo-organoid Approach for Harvesting Therapeutic Hematopoietic Stem/Progenitor Cells
Published on: February 16, 2024
Ultrastructural changes of stromal cells of bone marrow and liver after cyclophosphamide treatment in mice
1Departamento de Biología Celular e Histología, Facultad de Medicina, Universidad de Buenos Aires, Paraguay, Argentina.
Abstract:
The direct effect of cyclophosphamide (CY) on bone marrow and liver stromal cells of DBA/2 and C57BL/6 mice after a single intraperitoneal dose of 300 mg/kg, was assessed. Ultrastructural observations were carried out 2,4,6,12,18, and 24 h and 2,3,5,7,10,15,22 and 30 days after CY in femoral bone marrow and liver fixed by immersion or vascular perfusion. A massive depletion of hemopoietic cells was observed in bone marrow as early as 12 h after CY treatment, and normality was recovered only after 10 days. Among stromal cells, sinus endothelial cells, reticular cells, and macrophages were particularly sensitive to CY and showed severe damage as soon as 2 h after treatment. There was also an important dilatation of sinusoids, and the presence of mature red cells in the hemopoietic parenchyma, and macrophages and immature cells in the lumen and in circulating blood demonstrated the loss of integrity of the endothelium. In the liver, injured cells showing vesiculation and disruption of endothelial and Kupffer cells of sinusoids were evident 6 h after CY. The alterations caused by CY were transient. Although recovery of the hemopoietic cells in bone marrow and liver was achieved by day 10, the stromal cells showed damage even 15 days after CY, and a return to normality was only reached on day 30. Thus, the effect of CY on stromal cells, that was longer lasting than the effect on the hemopoietic compartment, demonstrated a higher recovery capacity of hemopoiesis with respect to stromal cells. These results demonstrate that recovery of hemopoiesis occurred even while the severe damage inflicted by CY to the stromal cells remained unrepaired.
Insights
Cyclophosphamide (CY) severely damages bone marrow and liver stromal cells, with hemopoietic cells recovering in 10 days. However, stromal cell damage persists longer, showing slower recovery than hemopoiesis.
Area of Science:
- Hematology
- Toxicology
- Cell Biology
Background:
- Cyclophosphamide (CY) is a widely used chemotherapeutic agent.
- Understanding its impact on bone marrow and liver stromal cells is crucial for managing toxicity.
- Stromal cells play a vital role in maintaining tissue architecture and supporting cell regeneration.
Purpose of the Study:
- To investigate the direct effects of cyclophosphamide on bone marrow and liver stromal cells.
- To compare the recovery timelines of hemopoietic and stromal compartments after CY treatment.
- To assess the ultrastructural changes induced by CY in murine models.
Main Methods:
- DBA/2 and C57BL/6 mice received a single intraperitoneal dose of cyclophosphamide (300 mg/kg).
- Femoral bone marrow and liver tissues were collected at various time points (hours to days) post-treatment.
- Ultrastructural observations were performed using electron microscopy on fixed tissue samples.
Main Results:
- Massive depletion of hemopoietic cells occurred within 12 hours, with recovery by day 10.
- Stromal cells (endothelial, reticular, macrophages) showed severe damage as early as 2 hours post-CY.
- Liver sinusoidal endothelial and Kupffer cells were injured by 6 hours; stromal damage persisted up to 15 days, with full recovery by day 30.
Conclusions:
- Cyclophosphamide induces transient but severe damage to both hemopoietic and stromal cells.
- Stromal cell recovery is significantly slower than hemopoietic cell recovery after CY exposure.
- The study highlights the resilience of hemopoiesis despite persistent damage to the stromal microenvironment.
More Related Videos
11:25Busulfan as a Myelosuppressive Agent for Generating Stable High-level Bone Marrow Chimerism in Mice
Published on: April 1, 2015
14:43Differentiating Functional Roles of Gene Expression from Immune and Non-immune Cells in Mouse Colitis by Bone Marrow Transplantation
Published on: October 1, 2012